These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy. Kuhlmann J Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430 [TBL] [Abstract][Full Text] [Related]
3. Cytostatic drugs are without significant effect on digitoxin plasma level and renal excretion. Kuhlmann J; Wilke J; Rietbrock N Clin Pharmacol Ther; 1982 Nov; 32(5):646-51. PubMed ID: 6897028 [TBL] [Abstract][Full Text] [Related]
4. [Action of certain antimitotic and immunosuppressive drugs on the electrophoretic mobility of human lymphocytes. Comparison with their action on blood platelets and red cells]. Larcan A; Stoltz JF; Puchelle JC; Streiff F Biomedicine; 1974 Sep; 20(5):352-7. PubMed ID: 4141631 [No Abstract] [Full Text] [Related]
5. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
6. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma. Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407 [TBL] [Abstract][Full Text] [Related]
7. The clinical pharmacology of antineoplastic agents (second of two parts). Chabner BA; Myers CE; Coleman CN; Johns DG N Engl J Med; 1975 May; 292(22):1159-68. PubMed ID: 47611 [No Abstract] [Full Text] [Related]
9. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage. Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285 [TBL] [Abstract][Full Text] [Related]
18. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A; J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521 [TBL] [Abstract][Full Text] [Related]
19. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of the enteral efficacy of digoxin, acetyldigoxin and digitoxin]. Benthe HF; Chenpanich K Arzneimittelforschung; 1965 May; 15(5):486-9. PubMed ID: 5898287 [No Abstract] [Full Text] [Related] [Next] [New Search]